ACE and Hypertension: The 2017 American College of Cardiology (ACC)/American Heart Association (AHA) hypertension guidelines recommend four classes of agents as first-line therapy for managing essential hypertension, and among them are angiotensin-converting enzyme (ACE) inhibitors [3].